Infratil Limited To Sell New Zealand Bus To Next Capital

Infratil Limited To Sell New Zealand Bus To Next Capital

To funds controlled by Next Capital, Infratil Limited (ASX: IFT) today announced a conditional sale of its 100% interest in its NZ Bus business (NZ Bus). The agreement is provisional on counterparty consensuses to the Overseas Investment Office approval, change of control and standard material adverse change clauses, as well as full documentation of the vendor loan. The transaction is expected to be around 30 June 2019 subject to the satisfaction of the conditions, completion. [optin-monster-shortcode id=”swikrbu1d9j9aq0o4cko”]

Infratil expects to receive proceeds of approximately $218 – 240 million, on completion of the transaction, with final proceeds adjusted for normal working capital, net debt, capital expenditure, and an earnout. A vendor loan of between $20 and $30 million repayable within 5.5 years of completion are included in the proceeds. Kevin Baker, Morrison & Co executive and NZ Bus Chairman.

The conditional sale agreement allows Infratil to focus its investments on its established platforms targeting retirement services, renewable energy, and growth in data and connectivity and enables NZ Bus to continue to grow its business and people under new ownership.

Following prior successful investments in GoBus in NZ and Forest Coach Lines in Australia, Next Capital is excited about its re-entry into this important sector and considers that the bus industry provides the core public transport function in NZ’s dynamic metropolitan environments. To deliver superior public transport outcomes across New Zealand and drive the long-term success of this iconic NZ business, they look forward to continuing the NZ Bus journey and to the opportunity partnering with Greater Wellington Regional Council, Auckland Transport and Bay of Plenty Regional Council. On the strategic review and the transaction, UBS New Zealand advised Infratil, and Murray & Co advised Next Capital.

Infratil Limited (ASX: IFT) traded flat at $3.600 as at December 24, 2018 and has seen a performance change of 22.03% in the last one year.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report